SCHEMBL24916306

SCHEMBL24916306

COc1cc(CO)c2nccc(Br)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
DYRK1A Q13627 2/20 0.37
KDM4E B2RXH2 5/20 0.36
TP53 P04637 3/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
HSP90AA1 P07900 2/20 0.36
TSHR P16473 1/20 0.36
ALOX12 P18054 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
KMT2A Q03164 1/20 0.36
DYRK3 O43781 1/20 0.36
CLK1 P49759 1/20 0.36
CLK2 P49760 1/20 0.36
CLK3 P49761 1/20 0.36
DYRK2 Q92630 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29923413 1.00 CYP19A1 (0.38) CYP19A1DYRK1AKDM4ETP53LMNA
SCHEMBL24916137 0.87 NSD2 (0.38) KDM4ETP53LMNAMAPTHTT
SCHEMBL29923321 0.87 NSD2 (0.38) KDM4ETP53LMNAMAPTHTT
SCHEMBL29923349 0.85 KDM4E (0.38) KDM4ETP53LMNAMAPTHTT
SCHEMBL24915807 0.85 KDM4E (0.38) KDM4ETP53LMNAMAPTHTT
SCHEMBL24916429 0.80 NSD2 (0.39) CYP19A1DYRK1AKDM4ETP53LMNA
SCHEMBL29923592 0.79 KDM4E (0.49) KDM4ETP53LMNAMAPTHTT
SCHEMBL24916107 0.79 KDM4E (0.38) KDM4EHSP90AA1NSD2CASP6CCR1
SCHEMBL24916498 0.79 KDM4E (0.49) KDM4ETP53LMNAMAPTHTT
SCHEMBL29923797 0.79 KDM4E (0.38) KDM4EHSP90AA1NSD2CASP6CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055013-B1 WDR5 INHIBITORS AND MODULATORS UNIV VANDERBILT (US) 2024-03-20 EP disclosed
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed
EP-4055013-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2022-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 CYP19A1 4616/4885DYRK1A 2337/4885KDM4E 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.